Real-time enrollment status for this gynecologic cancer clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 1:59 AM UTC
| NCT Number | NCT05758688 |
| Recruiting Status | Recruiting |
| Condition | Gynecologic Cancer |
| Phase | PHASE2 |
| Target Enrollment | 25 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Abramson Cancer Center at Penn Medicine |
| Last Updated on CT.gov | September 17, 2026 (4 weeks ago) |
As of October 16, 2026: Clinical trial NCT05758688 is currently recruiting participants. This phase2 study for gynecologic cancer is actively seeking new participants at 3 locations across the United States. The study is sponsored by Abramson Cancer Center at Penn Medicine. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05758688 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05758688 was last updated 4 weeks ago (September 17, 2026). HelloStudys verifies this status automatically.